Cite Filings / RNAZ / 0001104659-26-084636

Feed Companies Filings Check

Sign in

SCHEDULE 13D/A

Beneficial Ownership Report

Transcode Therapeutics, Inc. Filed 2026-07-17 Acc 0001104659-26-084636

Documents 1

SCHEDULE 13D/A Beneficial Ownership Report , xslSCHEDULE_13D_X02/primary_doc.xml

Around this filing

2026-07-23 SCHEDULE 13D/A Beneficial Ownership Report
2026-07-20 424B3 Prospectus
2026-07-20 424B3 Prospectus
2026-07-17 SCHEDULE 13D/A Beneficial Ownership Report
2026-07-17 DEFA14A Proxy Materials
2026-07-17 8-K Shareholder rights changed · Bylaws or fiscal year change
2025-10-28 SCHEDULE 13D/A Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…